Jpmorgan Chase & CO Ironwood Pharmaceuticals Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 306,865 shares of IRWD stock, worth $1.09 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

306,865

Previous 1,853,005 83.44%

Holding current value

$1.09 Million

Previous $12.1 Million 89.56%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$3.93 - $7.04 $6.08 Million - $10.9 Million	-1,546,140 Reduced 83.44%	306,865 $1.26 Million
Q2 2024 Aug 12, 2024	BUY	$5.58 - $8.61 $3.73 Million - $5.75 Million	667,780 Added 56.34%	1,853,005 $12.1 Million
Q1 2024 May 10, 2024	SELL	$8.32 - $15.45 $2.24 Million - $4.17 Million	-269,656 Reduced 18.53%	1,185,225 $10.3 Million
Q4 2023 Feb 12, 2024	BUY	$8.79 - $11.51 $8.56 Million - $11.2 Million	973,576 Added 202.28%	1,454,881 $16.6 Million
Q3 2023 Nov 14, 2023	SELL	$8.25 - $11.35 $6.68 Million - $9.18 Million	-809,116 Reduced 62.7%	481,305 $4.63 Million
Q2 2023 Aug 11, 2023	BUY	$10.1 - $11.6 $6.62 Million - $7.6 Million	655,313 Added 103.18%	1,290,421 $13.7 Million
Q1 2023 May 18, 2023	BUY	$10.37 - $12.56 $1.76 Million - $2.14 Million	170,068 Added 36.57%	635,108 $6.68 Million
Q1 2023 May 11, 2023	SELL	$10.37 - $12.56 $15.8 Million - $19.1 Million	-1,523,587 Reduced 76.62%	465,040 $4.89 Million
Q4 2022 Feb 13, 2023	BUY	$9.9 - $12.43 $13.9 Million - $17.5 Million	1,407,459 Added 242.18%	1,988,627 $24.6 Million
Q3 2022 Nov 14, 2022	SELL	$10.14 - $12.38 $1.38 Million - $1.69 Million	-136,236 Reduced 18.99%	581,168 $6.02 Million
Q2 2022 Aug 11, 2022	SELL	$11.05 - $12.72 $833,125 - $959,037	-75,396 Reduced 9.51%	717,404 $8.27 Million
Q1 2022 May 11, 2022	SELL	$10.61 - $12.88 $5.14 Million - $6.24 Million	-484,108 Reduced 37.91%	792,800 $9.97 Million
Q4 2021 Feb 10, 2022	SELL	$10.86 - $13.95 $5.31 Million - $6.83 Million	-489,386 Reduced 27.71%	1,276,908 $14.9 Million
Q3 2021 Nov 12, 2021	BUY	$11.92 - $13.92 $21.1 Million - $24.6 Million	1,766,294 New	1,766,294 $23.1 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $542M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ironwood Pharmaceuticals Inc Transaction History